Arena Capital Advisors’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-69,000
| Closed | -$708K | – | 65 |
|
|
2023
Q2 | $708K | Hold |
69,000
| – | – | 2.37% | 11 |
|
|
2023
Q1 | $698K | Hold |
69,000
| – | – | 0.97% | 19 |
|
|
2022
Q4 | $688K | Hold |
69,000
| – | – | 0.38% | 47 |
|
|
2022
Q3 | $671K | Hold |
69,000
| – | – | 0.2% | 80 |
|
|
2022
Q2 | $669K | Sell |
69,000
-257,328
| -79% | -$2.49M | 0.17% | 92 |
|
|
2022
Q1 | $3.17M | Buy |
326,328
+250,000
| +328% | +$2.43M | 0.48% | 71 |
|
|
2021
Q4 | $749K | Buy |
76,328
+14
| +0% | +$137 | 0.07% | 184 |
|
|
2021
Q3 | $750K | Buy |
+76,314
| New | +$750K | 0.06% | 196 |
|